Home › Companies › Black Diamond Therapeutics, Inc. › 2025-2026
At Black Diamond Therapeutics, Inc.'s shareholder meeting held June 26, 2026, in the 2025-2026 proxy season, 85 asset managers reported how they voted in their SEC Form N-PX filings, covering 491 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — Black Diamond Therapeutics, Inc.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Black Diamond Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 29, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Black Diamond Therapeutics, Inc.’s Form 8-K, filed June 29, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 26, 2026: 4 items on Black Diamond Therapeutics, Inc.’s Form 8-K, filed June 29, 2026: 2 approved · 2 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2025-2026
Explore Black Diamond Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Black Diamond Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 29, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Shannon Campbell | 19,251,021 | -- | -- | 17,219,135 | 8,220,339 | 52.8% | Not verified | — |
| Elect Director: Kapil Dhingra | 13,966,232 | -- | -- | 22,503,924 | 8,220,339 | 38% | Not verified | — |
| 2. Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 44,421,545 | 117,976 | 150,974 | -- | 0 | 99.7% | Approved | — |
| 3. Non-binding, advisory vote on the compensation of the Company's named executive officers | 35,071,684 | 1,243,945 | 154,527 | -- | 8,220,339 | 97% | Approved | — |
Source: Black Diamond Therapeutics, Inc., Form 8-K, filed with the SEC on June 29, 2026 — read the filing on EDGAR.
Each item below shows how the 85 asset managers that disclosed a Black Diamond Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Black Diamond Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
38% Plurality election · of votes cast
Description as filed by funds: Election of Class III Directors: Kapil Dhingra
Black Diamond Therapeutics, Inc.’s own tally for this item (“Elect Director: Kapil Dhingra”): 13,966,232 for, 22,503,924 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 38% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 464,916 for, 10,875,099 withheld, 46 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 6,330,730 | Withhold |
| Vanguard | 2,690 | 0 | 46 | 1,913,912 | Withhold |
| BlackRock | 0 | 0 | 0 | 539,509 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 533,000 | Withhold |
| Dimensional | 0 | 0 | 0 | 493,261 | Withhold |
| Fidelity | 333,279 | 0 | 0 | 80,838 | Mixed |
| Northern Trust | 0 | 0 | 0 | 270,315 | Withhold |
| EA Series Trust | 0 | 0 | 0 | 236,485 | Withhold |
| Northwestern Mutual | 0 | 0 | 0 | 201,600 | Withhold |
| Invesco | 98,508 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 91,046 | Withhold |
| WisdomTree | 0 | 0 | 0 | 86,986 | Withhold |
| John Hancock | 0 | 0 | 0 | 41,690 | Withhold |
| Legg Mason | 16,831 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 14,484 | Withhold |
| Goldman Sachs | 13,608 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 11,160 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 9,825 | Withhold |
| Equitable | 0 | 0 | 0 | 7,534 | Withhold |
| Victory Capital | 0 | 0 | 0 | 5,119 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 4,590 | Withhold |
| ProShares | 0 | 0 | 0 | 2,318 | Withhold |
| Nationwide | 0 | 0 | 0 | 471 | Withhold |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 226 | Withhold |
Combines 3 wordings of this item as funds reported it.
52.8% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Shannon Campbell
Black Diamond Therapeutics, Inc.’s own tally for this item (“Elect Director: Shannon Campbell”): 19,251,021 for, 17,219,135 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 52.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 3,535,225 for, 7,804,801 withheld, 35 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 6,330,730 | Withhold |
| Vanguard | 1,916,613 | 0 | 35 | 0 | For |
| BlackRock | 539,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 533,000 | Withhold |
| Dimensional | 0 | 0 | 0 | 493,261 | Withhold |
| Fidelity | 411,287 | 0 | 0 | 2,830 | For |
| Northern Trust | 270,315 | 0 | 0 | 0 | For |
| EA Series Trust | 236,485 | 0 | 0 | 0 | For |
| Northwestern Mutual | 0 | 0 | 0 | 201,600 | Withhold |
| Invesco | 98,508 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 91,046 | Withhold |
| WisdomTree | 0 | 0 | 0 | 86,986 | Withhold |
| John Hancock | 0 | 0 | 0 | 41,690 | Withhold |
| Legg Mason | 16,831 | 0 | 0 | 0 | For |
| Charles Schwab | 14,484 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,608 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 11,160 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 9,825 | 0 | 0 | 0 | For |
| Equitable | 7,534 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 5,119 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 4,590 | Withhold |
| ProShares | 0 | 0 | 0 | 2,318 | Withhold |
| Nationwide | 0 | 0 | 0 | 471 | Withhold |
| Advisors' Inner Circle Fund III | 226 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.
Black Diamond Therapeutics, Inc.’s own tally for this item (“3. The non-binding, advisory vote on the compensation of the Company's named executive officers”): 35,071,684 for, 1,243,945 against — passed, per its Form 8-K filed June 29, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 The Company's stockholders approved the non-binding, advisory vote on the compensation of the Company's named executive officers.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,330,730 | 0 | 0 | 0 | For |
| Vanguard | 1,916,645 | 2 | 0 | 0 | For |
| BlackRock | 539,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 533,000 | 0 | 0 | Against |
| Dimensional | 493,261 | 0 | 0 | 0 | For |
| Fidelity | 414,117 | 0 | 0 | 0 | For |
| Northern Trust | 270,315 | 0 | 0 | 0 | For |
| EA Series Trust | 236,485 | 0 | 0 | 0 | For |
| Northwestern Mutual | 201,600 | 0 | 0 | 0 | For |
| Invesco | 98,508 | 0 | 0 | 0 | For |
| American Century | 91,046 | 0 | 0 | 0 | For |
| WisdomTree | 86,986 | 0 | 0 | 0 | For |
| John Hancock | 41,690 | 0 | 0 | 0 | For |
| Legg Mason | 16,831 | 0 | 0 | 0 | For |
| Charles Schwab | 14,484 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,608 | 0 | 0 | 0 | For |
| Jackson National | 11,160 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 9,825 | 0 | 0 | 0 | For |
| Equitable | 7,534 | 0 | 0 | 0 | For |
| Victory Capital | 5,119 | 0 | 0 | 0 | For |
| Prudential/PGIM | 4,590 | 0 | 0 | 0 | For |
| ProShares | 2,318 | 0 | 0 | 0 | For |
| Nationwide | 0 | 471 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 226 | 0 | 0 | 0 | For |
Fund voting reports, all 24 managers: 10,806,587 for, 533,473 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 10,464,294 | 0 | 0 | 0 | For |
| Versant Venture Management, LLC | 6,206,964 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 4,449,845 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 1,889,233 | 17,418 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 753,682 | 0 | 0 | 0 | For |
| MACKENZIE FINANCIAL CORP | 679,979 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 543,300 | 0 | 0 | Against |
| Fidelity | 399,682 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 384,863 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 358,593 | 0 | 0 | 0 | For |
| Vanguard | 284,293 | 0 | 0 | 0 | For |
| Round Rock Advisors LLC | 273,277 | 0 | 0 | 0 | For |
| BlackRock | 256,080 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 247,958 | 0 | 0 | 0 | For |
| Winton Capital Management Ltd | 219,396 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 201,568 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 179,475 | 0 | 0 | 0 | For |
| CANADA PENSION PLAN INVESTMENT BOARD | 173,300 | 0 | 0 | 0 | For |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 172,733 | 0 | 0 | 0 | For |
| Renaissance | 162,996 | 0 | 0 | 0 | For |
| DE Shaw | 124,949 | 0 | 0 | 0 | For |
| Invesco | 98,508 | 0 | 0 | 0 | For |
| American Century | 91,046 | 0 | 0 | 0 | For |
| Dimensional | 90,705 | 0 | 0 | 0 | For |
| Northern Trust | 89,786 | 0 | 0 | 0 | For |
Institutional-manager reports, all 72 managers: 28,626,310 for, 650,885 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
— Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Non-binding, advisory vote on the preferred frequency of future non- binding, advisory votes to approve the compensation of the Company's named executive officers.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| EA Series Trust | 0 | 0 | 0 | 0 | -- |
| Northwestern Mutual | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| WisdomTree | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Legg Mason | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 24 managers: 10,827,417 1 year, 509,011 3 year, 3,633 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| NEA Management Company, LLC | 0 | 0 | 0 | 0 | -- |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 0 | 0 | 0 | -- |
| MACKENZIE FINANCIAL CORP | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0 | 0 | 0 | 0 | -- |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Round Rock Advisors LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| 683 Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| Winton Capital Management Ltd | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| CANADA PENSION PLAN INVESTMENT BOARD | 0 | 0 | 0 | 0 | -- |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Man Group plc | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 70 managers: 18,529,670 1 year, 4,540,550 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as Black Diamond Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Black Diamond Therapeutics, Inc.’s own tally for this item (“2. Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 44,421,545 for, 117,976 against — passed, per its Form 8-K filed June 29, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 11,340,061 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,330,730 | 0 | 0 | 0 | For |
| Vanguard | 1,916,648 | 0 | 0 | 0 | For |
| BlackRock | 539,509 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 533,000 | 0 | 0 | 0 | For |
| Dimensional | 493,261 | 0 | 0 | 0 | For |
| Fidelity | 414,117 | 0 | 0 | 0 | For |
| Northern Trust | 270,315 | 0 | 0 | 0 | For |
| EA Series Trust | 236,485 | 0 | 0 | 0 | For |
| Northwestern Mutual | 201,600 | 0 | 0 | 0 | For |
| Invesco | 98,508 | 0 | 0 | 0 | For |
| American Century | 91,046 | 0 | 0 | 0 | For |
| WisdomTree | 86,986 | 0 | 0 | 0 | For |
| John Hancock | 41,690 | 0 | 0 | 0 | For |
| Legg Mason | 16,831 | 0 | 0 | 0 | For |
| Charles Schwab | 14,484 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,608 | 0 | 0 | 0 | For |
| Jackson National | 11,160 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 9,825 | 0 | 0 | 0 | For |
| Equitable | 7,534 | 0 | 0 | 0 | For |
| Victory Capital | 5,119 | 0 | 0 | 0 | For |
| Prudential/PGIM | 4,590 | 0 | 0 | 0 | For |
| ProShares | 2,318 | 0 | 0 | 0 | For |
| Nationwide | 471 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 226 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 57,301,774 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 11.05% |
| 2 | Vanguard | 3.34% |
| 3 | BlackRock | 0.94% |
| 4 | BRIDGEWAY FUNDS INC | 0.93% |
| 5 | Dimensional | 0.86% |
| 6 | Fidelity | 0.72% |
| 7 | Northern Trust | 0.47% |
| 8 | EA Series Trust | 0.41% |
| 9 | Northwestern Mutual | 0.35% |
| 10 | Invesco | 0.17% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 18.26% |
| 2 | Versant Venture Management, LLC | 10.83% |
| 3 | NEA Management Company, LLC | 7.77% |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 3.33% |
| 5 | Connor, Clark & Lunn Investment Management Ltd. | 1.32% |
| 6 | MACKENZIE FINANCIAL CORP | 1.19% |
| 7 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.95% |
| 8 | Fidelity | 0.70% |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.67% |
| 10 | STIFEL NICOLAUS & CO INC \MO\ | 0.63% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities affiliated with T. Rowe Price Investment Management | 18.73% | DEF14A |
| Entities affiliated with Versant Venture Capital | 10.83% | DEF14A |
| Entities affiliated with New Enterprise Associates | 7.76% | DEF14A |
| T. Rowe Price Investment Management, Inc. | 7.03% | 13G |
| Vanguard Group | 3.82% | 13F |
| Renaissance Technologies | 2.87% | 13F |
| Dimensional Fund Advisors | 2.27% | 13F |
| Mark A. Velleca, M.D., Ph.D. | 2.27% | DEF14A |
| BlackRock | 1.93% | 13F |
| Vestal Point Capital, LP | 1.52% | 13G |
Percentages above are of 57,301,774 shares outstanding, as reported by Black Diamond Therapeutics, Inc. on its Form 10-Q dated May 1, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Black Diamond Therapeutics, Inc.’s 10-Q dated May 1, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Black Diamond Therapeutics, Inc. proxy season coverage: 2025-2026 (this page).
proxyvotesnow.com, “Black Diamond Therapeutics (BDTX) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/black-diamond-therapeutics-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.